EGLN2 and cancer: Unlike in other cancer cells, the expression of cyclin D1 in MCL is neither regulated by EGLN2/PHD1 nor by FOXO3A; thus, the molecular mechanism controlling cyclin D1 production and degradation in MCL remains to be elucidated.